CTT Pharmaceutical Holdings, Inc.
CTTH
$0.0632
$0.00315.16%
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 404.86% | 26,733.33% | 12,417.65% | 8,180.00% | 408.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 404.86% | 26,733.33% | 12,417.65% | 8,180.00% | 408.24% |
| Operating Income | -404.86% | -26,733.33% | -12,417.65% | -8,180.00% | -408.24% |
| Income Before Tax | -691.44% | -40,200.00% | -19,729.41% | -8,280.00% | -408.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -691.44% | -40,200.00% | -19,729.41% | -8,280.00% | -408.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -691.44% | -40,200.00% | -19,729.41% | -8,280.00% | -408.24% |
| EBIT | -404.86% | -26,733.33% | -12,417.65% | -8,180.00% | -408.24% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -492.59% | -16,900.00% | -17,200.00% | -6,260.00% | -350.00% |
| Normalized Basic EPS | -488.24% | -- | -10,700.00% | -6,533.33% | -325.00% |
| EPS Diluted | -492.59% | -16,900.00% | -17,200.00% | -6,260.00% | -350.00% |
| Normalized Diluted EPS | -488.24% | -- | -10,700.00% | -6,533.33% | -325.00% |
| Average Basic Shares Outstanding | 35.20% | 42.91% | 30.76% | 32.37% | 5.70% |
| Average Diluted Shares Outstanding | 35.20% | 42.91% | 30.76% | 32.37% | 5.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |